Does meclofenamate cause hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Meclofenamate is not mentioned in the provided evidence, however, based on the available information about other medications, we can conclude that the question is about the potential of meclofenamate to cause hypotension, which is not directly answered by the provided studies. However, we can discuss the potential effects of meclofenamate on blood pressure based on its pharmacological properties. Meclofenamate is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting the production of prostaglandins, which are substances in the body that can cause pain and inflammation. Some NSAIDs can cause an increase in blood pressure or worsen existing hypertension, but the effect of meclofenamate on blood pressure is not well-studied in the provided evidence.

The most relevant study to the question of hypotension is the one on orthostatic side effects of clomipramine and moclobemide during treatment for depression 1, which shows that moclobemide does not induce orthostatic side effects, but this study does not mention meclofenamate. Another study on the management of low blood pressure in ambulatory heart failure with reduced ejection fraction patients 2 provides general information on the management of hypotension, but does not discuss meclofenamate specifically.

Given the lack of direct evidence on meclofenamate, it is not possible to make a definitive statement about its potential to cause hypotension, and more research is needed to fully understand its effects on blood pressure. However, based on the general principles of pharmacology and the potential effects of NSAIDs on blood pressure, it is likely that meclofenamate would not typically cause hypotension as a common side effect, but this should be confirmed by further studies.

Some key points to consider when evaluating the potential effects of meclofenamate on blood pressure include:

  • The mechanism of action of meclofenamate as an NSAID and its potential effects on prostaglandins and blood pressure
  • The lack of direct evidence on meclofenamate in the provided studies
  • The general principles of pharmacology and the potential effects of NSAIDs on blood pressure
  • The need for further research to fully understand the effects of meclofenamate on blood pressure.

Related Questions

What is the best course of action for a 27-year-old female patient with a history of palpitations, lightheadedness, and dizziness, currently taking Bupropion Hydrochloride (Wellbutrin) ER 300 mg daily, Lisdexamfetamine Dimesylate (Vyvanse) 30 mg daily, and Drospirenone-Ethinyl Estradiol (Yaz) 3-0.02 mg daily, who recently experienced frequent premature ventricular contractions (PVCs) and anxiety?
What medication adjustments can be made to counter hypotension in a patient with Heart Failure with Reduced Ejection Fraction (HFrEF)?
What to do for asymptomatic hypotension with a blood pressure reading of 74/47 mmHg?
What medications are used to treat hypotension?
What is the best treatment option for a 27-year-old female with palpitations, anxiety, and dizziness, who is taking Vyvanse (lisdexamfetamine) and Wellbutrin (bupropion), and has a history of orthostatic hypotension and Raynaud's-like phenomenon, and refuses to stop or decrease the dose of her current medications?
Is azithromycin (a macrolide antibiotic) a sulfonamide (sulfa)?
What medication should be given to a patient undergoing dialysis with diabetes mellitus (Diabetes) and impaired renal function?
What does a positive scarf test on shoulder examination indicate?
What is the incidence of fever in a 5-month-old infant?
What are the management considerations for a 69-year-old female patient with osteoporosis on Forteo (teriparatide) who has shown no improvement in bone density after a repeat Dual-Energy X-ray Absorbency (DEXA) scan?
What is the efficacy of dexamethasone in the Neonatal Intensive Care Unit (NICU) population?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.